Otros idiomas COMPASS Pathways plc

Acciones

CMPS

US20451W1018

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 28/05/2024			Varia. Cinco días.	Varia. 1 de enero.
7,44 ^USD	-0,53 %		-5,46 %	-14,97 %

09/05	Transcript : COMPASS Pathways plc - Shareholder/Analyst Call
08/05	Transcript : COMPASS Pathways plc, Q1 2024 Earnings Call, May 08, 2024

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Inscripción 100% Gratuita

Clarify Pharma confirms name change to File Forge	22/05
COMPASS Pathways : 2024 AGM Voting Results	13/05
COMPASS Pathways plc Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05
Compass Pathways Announces First Quarter 2024 Financial Results and Business Highlights	08/05
Compass Pathways plc Reports Top-Line Results from an Open-Label Phase 2 Study Evaluating the Safety and Tolerability of Investigational COMP360 Psilocybin Treatment in 22 Patients with Post-Tail Stress Disorder	08/05
Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 study of COMP360 psilocybin in post-traumatic stress disorder	08/05
Compass Pathways establishes research collaboration with Mindful Health Solutions to inform the development of a scalable and cost-effective delivery model for investigational COMP360 psilocybin treatment	02/05
Compass Pathways and Journey Clinical establish research collaboration agreement to inform the training of healthcare providers and delivery model for COMP360 psilocybin treatment, if approved for treatment-resistant depression	29/04
Compass Pathways and Journey Clinical Establish Research Collaboration Agreement to Inform the Training of Healthcare Providers and Delivery Model for Comp360 Psilocybin Treatment, If Approved for Treatment-Resistant Depression	29/04
Compass Pathways Insider Sold Shares Worth $597,964, According to a Recent SEC Filing	18/04
Compass Pathways Insider Sold Shares Worth $597,964, According to a Recent SEC Filing	18/04
Clarify Pharma to change name to File Forge Technology	17/04
Compass Pathways Insider Sold Shares Worth $461,332, According to a Recent SEC Filing	02/04
Compass Pathways Insider Sold Shares Worth $461,332, According to a Recent SEC Filing	02/04
Compass Pathways Insider Sold Shares Worth $445,552, According to a Recent SEC Filing	01/04
Compass Pathways Insider Sold Shares Worth $445,552, According to a Recent SEC Filing	01/04
ADRs End Lower; NuCana Slides 15%	28/03
Compass Pathways Co-Founders Step Down From Board; David Norton Named Interim Chair; Shares Fall	28/03
COMPASS Pathways plc Announces Board Changes	28/03
Compass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia Step Down from Board of Directors	28/03

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas COMPASS Pathways plc

Acciones

CMPS

US20451W1018

Otros idiomas

Filtros